Pathology Instruments

Pathology Instruments Market by Instruments (Centrifuges, Cytometers, Digital Pathology Solutions), Application (Anatomic Pathology, Clinical Pathology, Molecular Pathology), End-User - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the pathology instruments market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[195 Pages Report] The Pathology Instruments Market size was estimated at USD 7.46 billion in 2023 and expected to reach USD 7.94 billion in 2024, at a CAGR 7.11% to reach USD 12.07 billion by 2030.

Pathology Instruments Market
To learn more about this report, request a free PDF copy

Pathology instruments are specialized tools and equipment used in the examination of tissues and body fluids to diagnose diseases. These instruments include microtomes for slicing tissue specimens, histology stain systems for color-coding cells and tissue components, and analyzers that measure specific blood or urine sample markers. Pathology instruments are applied in histopathology, cytopathology, molecular pathology, and forensic pathology, among other fields. An increase in chronic diseases worldwide contributes to the need for diagnostic services and necessitates the deployment of highly efficient pathology instruments. Furthermore, growing healthcare expenditure by governments and support for deploying advanced pathology solutions can lead to increased investments in pathology facilities, aiding the growth of the market. However, the high costs of advanced pathology instruments may hinder their adoption. Additionally, errors associated with pathology instruments and difficulties in handling the instruments can further present challenges to the widespread utilization of pathology instruments. However, key players are investing in the integration of digital pathology systems and instruments with AI, and machine learning offers to improve and ease the adoption of pathology instruments. These systems can handle large data sets, improve diagnostic accuracy, and enhance workflow efficiency. Furthermore, collaborating with healthcare providers to develop integrated systems that connect pathology instruments with other medical devices and electronic health records can provide new avenues of growth for the industry.

Pathology Instruments Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Instruments: Efforts by key manufacturers to advance the capabilities of hematology instruments

Centrifuges are instrumental in sample preparation within pathology labs, as they separate components within a fluid by density using centrifugal force. Preference for particular models may be based on the sample capacity, speed requirements, footprint, and temperature control features. Cytometers, including flow cytometers, are critical in the quantification, detection, and sorting of cells and cellular components. High-throughput capabilities, sensitivity, and specificity of detection are key features driving preference. Digital pathology solutions and systems encompass entire services that facilitate the digital management, analysis, and interpretation of pathology slides. High image quality, scalability, and compatibility with different slide formats are favored features. Hematology instruments are used for complete blood count (CBC) and other blood tests, essential in disease diagnosis and monitoring. Immunohistochemistry (IHC) instruments enable the detection of antigens in tissue sections by exploiting the principle of binding of antibodies to antigens in biological samples. Incubators are used to grow, maintain, and multiply microbiological cultures or cell cultures at a constant temperature, humidity, and other conditions. Microtomes are devices used in microscopy to cut exceedingly thin slices of material for sample preparation. Ease of use, section uniformity, and safety features are among the top considerations for these instruments. Staining machines automate the process of staining tissue samples, which is essential for viewing tissue structures under a microscope. Tissue processors are vital for the preparation of tissue samples for histopathology. These instruments automate the fixation, dehydration, clearing, and infiltration of tissue specimens.

Application: R&D initiatives to support the innovations in molecular pathology

Anatomic pathology refers to the branch of pathology that deals with the study of the effects of disease on the structure of body organs, both gross (macroscopic) and microscopic levels. Pathology instruments in this category include tissue processors, slide stainers, microtomes, and cryostats. These instruments are integral for examining biopsy samples and diagnosing various diseases, including cancer. Clinical pathology, also known as laboratory medicine, involves the analysis of blood, urine, and other body fluids to diagnose diseases. Instruments used in this field include hematology analyzers, clinical chemistry analyzers, and immunoassay systems. The focus is generally on high efficiency and automation to process many samples and ensure quick turnaround times for patient results. Molecular pathology involves the study, identification, and diagnosis of chronic and genetic diseases through the examination of biomolecules and genes within organs, tissues, or bodily fluids. Pathology instruments here include PCR machines, DNA sequencers, and microarrays. These instruments are crucial for genetic testing, identifying infectious diseases, and detecting biomarkers for personalized medicine.

End-User: Expansion of diagnostic laboratories across the world to serve the critical demand for disease detection

Academic and research institutes primarily focus on the study and innovation of pathological practices. The pursuit of research in cellular and molecular analysis, tissue engineering, disease pathology, and drug discovery drives the need for advanced instruments. These institutions prefer high-end, precision instruments for accurate results, which are critical in research. Diagnostic laboratories require reliable and efficient pathology instruments to manage high volumes of patient samples for accurate diagnosis. Speed, automation, and integration capabilities are critical features for diagnostics laboratories to streamline workflows and increase throughput. Hospitals utilize pathology instruments to provide prompt and accurate diagnostic services, which is essential for treatment decisions. They balance the need for comprehensive testing capabilities with considerations such as space constraints and budget limitations.

Regional Insights

The Americas region, particularly the US and Canada, features a robust healthcare infrastructure characterized by the presence of several major players in the healthcare industry, which has driven the growth of the pathology instruments market. The region is also involved in the constant exploration of advanced digital technologies, including artificial intelligence (AI), machine learning (ML), and big data analytics, that have significantly enhanced the functionality and performance of pathology instruments. Stringent regulations by the European Union on in-vitro diagnostics and a well-established healthcare infrastructure foster market growth. Frequent collaboration between private and public entities to propel diagnostics capabilities has further led to constant innovations in pathology solutions and instruments. The Asia-Pacific region is exhibiting rapid growth in the pathology instruments market, with countries such as China, Japan, and India leading the expansion. China's market is burgeoning, fueled by large-scale healthcare reforms and growing investment in healthcare infrastructure. Additionally, the Chinese government's focus on public health and preventive healthcare measures adds to the increased demand for pathology services.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pathology Instruments Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pathology Instruments Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Metrion Biosciences Closes GBP 3.5 Million (USD 4.7 Million) Financing to Support Lab Expansion

    Metrion Biosciences, the UK-based company specializing in ion channel research and drug discovery, announced the successful investments of GBP 3.5 million (USD 4.7 million) in fresh equity financing. This strategic capital raise marks a pivotal step for Metrion Biosciences, poised to bolster its innovation and growth within the pathology instruments sector. [Published On: 2023-12-20]

  • PerkinElmer Acquires Life Sciences Firm Covaris

    PerkinElmer successfully acquired Covaris, a company specializing in life science technology. This acquisition catalyzes Covaris's expansion trajectory while enriching PerkinElmer's portfolio, particularly within the high-demand diagnostics market. Covaris's proficiency in next-generation sequencing (NGS) is a significant boon for PerkinElmer as it positions itself at the forefront of precision medicine. [Published On: 2023-12-05]

  • Versant Diagnostics Partners with Dahl-Chase Pathology and Diagnostic Groups

    Versant Diagnostics, an independent provider of physician services in the realm of anatomic pathology, announced a strategic collaboration with Dahl-Chase Pathology Associates and Dahl-Chase Diagnostic Services. This union is set to fortify Versant Diagnostics' service portfolio. Dahl-Chase is acclaimed for delivering comprehensive diagnostic solutions that span surgical pathology, histology, immunohistochemistry, cytology, flow cytometry, and molecular diagnostics. The collaboration is poised to enhance patient care by leveraging Dahl-Chase's expansive expertise with a mutual commitment to innovation and excellence in pathology services. [Published On: 2023-10-26]

Key Company Profiles

The report delves into recent significant developments in the Pathology Instruments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Amos Scientific Pty. Ltd., Becton, Dickinson and Company, Bio SB Inc., Bio-Genex Laboratories, Bio-Rad Laboratories, Inc., BRAND GMBH + CO KG, Carl Zeiss AG, Danaher Corporation, Diapath S.p.A., Diatron Group by STRATEC SE, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Hamamatsu Photonics K.K., Hamilton Company, Hologic, Inc., Horiba Corporation, Illumina Inc., Jinan Olabo Technology Co., Ltd., Koninklijke Philips N.V., Merck KGaA, Mikroscan Technologies, Inc., Nihon Kohden Corporation, Olympus Corporation, PerkinElmer Inc., PHC Holdings Corporation, QIAGEN N.V., RWD Life Science Co., Ltd., Sakura Finetek Japan Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., VOGEL MedTec GmbH, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Pathology Instruments Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Instruments
    • Centrifuges
    • Cytometers
    • Digital Pathology Solutions
    • Digital Pathology Systems
    • Hematology Instruments
    • Immunohistochemistry (IHC) Instruments
    • Incubators
    • Microtomes
    • Staining Machines
    • Tissue Processors
  • Application
    • Anatomic Pathology
    • Clinical Pathology
    • Molecular Pathology
  • End-User
    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pathology Instruments Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pathology Instruments Market?
  3. What are the technology trends and regulatory frameworks in the Pathology Instruments Market?
  4. What is the market share of the leading vendors in the Pathology Instruments Market?
  5. Which modes and strategic moves are suitable for entering the Pathology Instruments Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Pathology Instruments Market, by Instruments
  7. Pathology Instruments Market, by Application
  8. Pathology Instruments Market, by End-User
  9. Americas Pathology Instruments Market
  10. Asia-Pacific Pathology Instruments Market
  11. Europe, Middle East & Africa Pathology Instruments Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 300]
  16. List of Companies Mentioned [Total: 36]
A path to a diligent search of diseases: The advanced face of pathology instruments
March 20, 2024
INSIGHT
A path to a diligent search of diseases: The advanced face of pathology instruments
The relentless evolution of diseases with emerging new pathogens and increasingly complex chronic illnesses is universally raising the urgency for advanced and precise pathology instruments.

The Royal College of Pathologists says nearly 95% of clinical pathways rely on patients accessing pathology services. In the UK, 500 million biochemistry and 130 million hematology tests are carried out annually. With this number showing an exponentially big figure globally, the demand for pathology labs and services is on the cloud.

Pathology instruments play a heroic role in supporting the observation and examination of tissues and body fluids to detect diseases. Microtomes, histology stain systems, and analyzers are the primary technologies in pathology labs. Introducing new hospitals, pathology labs, and clinics is creating a new face for deploying pathology instruments.

In September 2023, a new advanced pathology laboratory at Nepean Hospital was set up as part of a USD 29 million investment in NSW Health Pathology laboratories in regional NSW and western Sydney. The new lab is fitted with next-generation chemical pathology analyzers that offer numerous tests, including liver and kidney function tests and diabetes monitoring.

Digitalization is the focus area of all pathology labs in today’s era, and emphasis on digital pathology and automation is constantly bolstering. AI-powered digital pathology solutions find space in laboratories and health systems worldwide and can transform pathology lab activities. This rise of new-age instruments and the wide expansion of pathology labs can make an evergreen potential for building a holistic diagnostic experience.

The Future of Pathology Instruments: Embracing Digital Solutions
August 13, 2023
BLOG
The Future of Pathology Instruments: Embracing Digital Solutions
Technology has significantly transformed healthcare, and pathology is no exception. Pathology instruments have come a long way from traditional microscopes and glass slide preparations. Pathology labs now have a wide range of digital solutions that enable faster and more accurate diagnostics of diseases. In this blog, we will explore the scope of pathology instruments and how digital pathology solutions are changing the way pathologists work.

What are pathology instruments?

Pathology instruments are medical devices used by pathologists to diagnose diseases through the analysis of human tissue samples. They include conventional instruments such as microscopes, centrifuges, and slide stainers, as well as digital pathology solutions such as whole-slide imaging, artificial intelligence, and image analysis software.

The Rise of Digital Pathology Instruments:

One of the major drivers of the shift towards digital pathology instruments is the increasing demand for faster and more accurate diagnostics. Conventional pathology instruments often require longer processing times and can be prone to human error. Digital pathology solutions, on the other hand, enable pathologists to process and analyze tissue samples faster and more accurately, thereby improving the quality of patient care.

Benefits of Digital Pathology Instruments:

Digital pathology instruments offer several benefits over traditional pathology instruments. For example, whole-slide imaging enables pathologists to view entire tissue specimens on a single computer screen, eliminating the need for physical slides. This not only saves time but also reduces the risk of lost or damaged slides. Artificial intelligence and image analysis software, meanwhile, can help pathology labs to process large amounts of data quickly and efficiently.

Challenges and Limitations of Digital Pathology Instruments:

Despite their potential benefits, digital pathology instruments are not without their challenges and limitations. For example, high costs associated with digital pathology instruments and the need for specialized expertise can limit their adoption in smaller pathology labs. Additionally, some pathologists may be hesitant to embrace digital solutions due to concerns about the accuracy and reliability of automated diagnostics.

The Future of Pathology Instruments:

As the healthcare industry continues to evolve, there is no doubt that digital pathology instruments will play an increasingly important role. In the years ahead, we can expect to see continued advances in artificial intelligence and image analysis software, as well as the development of more user-friendly digital pathology solutions. While there may be some resistance to digital pathology instruments in the short term, the benefits they offer are simply too great to ignore.

Digital pathology solutions are changing the way pathologists work by enabling faster and more accurate diagnostics of diseases. While there are still some challenges and limitations associated with digital pathology instruments, we can expect to see continued growth and adoption of these solutions in the years ahead. The rise of artificial intelligence and image analysis software is particularly promising, as these technologies can help pathology labs to process large amounts of data quickly and efficiently. Ultimately, embracing digital solutions will enable pathology labs to improve patient care and outcomes.

Frequently Asked Questions
  1. How big is the Pathology Instruments Market?
    Ans. The Global Pathology Instruments Market size was estimated at USD 7.46 billion in 2023 and expected to reach USD 7.94 billion in 2024.
  2. What is the Pathology Instruments Market growth?
    Ans. The Global Pathology Instruments Market to grow USD 12.07 billion by 2030, at a CAGR of 7.11%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.